COEP vs NCI
Comparison between Coeptis Therapeutics Holdings Inc. Common Stock (COEP, Company) and Neo Concept International Group Holdings Ltd (NCI, Company).
COEP is from the Healthcare sector, while NCI is from the Consumer Cyclical sector.
COEP vs NCI - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
COEP vs NCI - Historical Returns
Returns include dividend reinvestment.
COEP vs NCI - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | COEP | NCI |
|---|---|---|
| 2026 | N/A | +20.07% |
| 2025 | N/A | -62.35% |
| 2024 | N/A | -93.05% |
| 2022 | -29.92% | N/A |
| 2021 | +161.29% | N/A |
| 2020 | +4205.56% | N/A |
| 2019 | +133.33% | N/A |
| 2018 | +30.43% | N/A |
| 2017 | +53.33% | N/A |
| 2016 | -46.43% | N/A |
| 2015 | +11.43% | N/A |
| 2014 | -44.44% | N/A |
| 2013 | +950.00% | N/A |
| 2012 | -40.00% | N/A |
| 2011 | -92.31% | N/A |
| 2010 | -94.80% | N/A |
| 2009 | +25.00% | N/A |
| 2008 | +0.00% | N/A |
COEP vs NCI Drawdown Comparison
The maximum drawdown for COEP was -99.94%, occurring on Apr 13, 2012. Recovery took 2232 trading sessions.
The maximum drawdown for NCI was -98.96%, occurring on Apr 13, 2026. This drawdown has not yet recovered.
The current COEP drawdown is -58.13%. The current NCI drawdown is -97.12%.
| Rank | COEP | NCI |
|---|---|---|
| #1 | -99.94% Mar 22, 2010 - Aug 11, 2020 | -98.96% Apr 23, 2024 - Apr 13, 2026 |
| #2 | -96.95% Aug 11, 2020 - Jan 4, 2021 | N/A |
| #3 | -77.00% Feb 22, 2021 - Aug 29, 2022 | N/A |
| #4 | -60.00% Nov 19, 2009 - Mar 16, 2010 | N/A |
| #5 | -50.00% Dec 9, 2008 - Nov 19, 2009 | N/A |
| #6 | -27.50% Jan 6, 2021 - Jan 15, 2021 | N/A |
| #7 | -26.00% Jan 15, 2021 - Jan 28, 2021 | N/A |
| #8 | -24.24% Feb 11, 2021 - Feb 22, 2021 | N/A |
| #9 | -21.43% Feb 1, 2021 - Feb 9, 2021 | N/A |
| #10 | -15.48% Jan 4, 2021 - Jan 6, 2021 | N/A |
Correlation
Correlation between COEP and NCI is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks